ACADIA Pharmaceuticals
ACAD
#3573
Rank
HK$29.66 B
Marketcap
HK$174.00
Share price
-0.54%
Change (1 day)
34.60%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): HK$1.08 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are HK$1.07 Billion. a decrease over its 2024 earnings that were of HK$2.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 HK$1.08 B-46.18%
2024 HK$2.02 B-605.67%
2023 -HK$0.41 Billion-76.09%
2022 -HK$1.68 Billion27.41%
2021 -HK$1.32 Billion-40.38%
2020 -HK$2.21 Billion19.88%
2019 -HK$1.84 Billion-3.92%
2018 -HK$1.92 Billion-15.04%
2017 -HK$2.26 Billion6.33%
2016 -HK$2.12 Billion64.55%
2015 -HK$1.29 Billion77.47%
2014 -HK$0.73 Billion143.69%
2013 -HK$0.3 Billion81.93%
2012 -HK$0.17 Billion-8.73%
2011 -HK$0.18 Billion-251.39%
2010 HK$0.11 B-133.2%
2009 -HK$0.36 Billion-30.82%
2008 -HK$0.52 Billion6.43%
2007 -HK$0.49 Billion25.89%
2006 -HK$0.39 Billion36.99%
2005 -HK$0.29 Billion37.22%
2004 -HK$0.21 Billion19.96%
2003 -HK$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.97 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$79.88 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$201.67 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$73.11 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-HK$0.95 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-HK$0.31 Billion-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA